![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 2879 |
FusionGeneSummary for AR_NR4A3 |
![]() |
Fusion gene information | Fusion gene name: AR_NR4A3 | Fusion gene ID: 2879 | Hgene | Tgene | Gene symbol | AR | NR4A3 | Gene ID | 374 | 8013 |
Gene name | amphiregulin | nuclear receptor subfamily 4 group A member 3 | |
Synonyms | AR|AREGB|CRDGF|SDGF | CHN|CSMF|MINOR|NOR1|TEC | |
Cytomap | 4q13.3 | 9q31.1 | |
Type of gene | protein-coding | protein-coding | |
Description | amphiregulinamphiregulin Bcolorectum cell-derived growth factorschwannoma-derived growth factor | nuclear receptor subfamily 4 group A member 3chondrosarcoma, extraskeletal myxoid, fused to EWSmitogen-induced nuclear orphan receptorneuron-derived orphan receptor 1nuclear hormone receptor NOR-1translocated in extraskeletal chondrosarcoma | |
Modification date | 20180523 | 20180527 | |
UniProtAcc | P10275 | Q92570 | |
Ensembl transtripts involved in fusion gene | ENST00000374690, ENST00000513847, ENST00000504326, ENST00000396044, ENST00000396043, | ENST00000338488, ENST00000395097, ENST00000330847, | |
Fusion gene scores | * DoF score | 2 X 2 X 2=8 | 6 X 6 X 4=144 |
# samples | 2 | 10 | |
** MAII score | log2(2/8*10)=1.32192809488736 | log2(10/144*10)=-0.526068811667588 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: AR [Title/Abstract] AND NR4A3 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | AR | GO:0007173 | epidermal growth factor receptor signaling pathway | 12743035 |
Hgene | AR | GO:0007186 | G-protein coupled receptor signaling pathway | 12743035 |
Tgene | NR4A3 | GO:0010828 | positive regulation of glucose transmembrane transport | 24022864 |
Tgene | NR4A3 | GO:0045944 | positive regulation of transcription by RNA polymerase II | 20558821 |
Tgene | NR4A3 | GO:0048008 | platelet-derived growth factor receptor signaling pathway | 23554459 |
Tgene | NR4A3 | GO:0048660 | regulation of smooth muscle cell proliferation | 25852083 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | LIHC | TCGA-G3-A7M8-01A | AR | chrX | 66863249 | + | NR4A3 | chr9 | 102587941 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-5UTR | ENST00000374690 | ENST00000338488 | AR | chrX | 66863249 | + | NR4A3 | chr9 | 102587941 | + |
5CDS-5UTR | ENST00000374690 | ENST00000395097 | AR | chrX | 66863249 | + | NR4A3 | chr9 | 102587941 | + |
5CDS-intron | ENST00000374690 | ENST00000330847 | AR | chrX | 66863249 | + | NR4A3 | chr9 | 102587941 | + |
3UTR-5UTR | ENST00000513847 | ENST00000338488 | AR | chrX | 66863249 | + | NR4A3 | chr9 | 102587941 | + |
3UTR-5UTR | ENST00000513847 | ENST00000395097 | AR | chrX | 66863249 | + | NR4A3 | chr9 | 102587941 | + |
3UTR-intron | ENST00000513847 | ENST00000330847 | AR | chrX | 66863249 | + | NR4A3 | chr9 | 102587941 | + |
5CDS-5UTR | ENST00000504326 | ENST00000338488 | AR | chrX | 66863249 | + | NR4A3 | chr9 | 102587941 | + |
5CDS-5UTR | ENST00000504326 | ENST00000395097 | AR | chrX | 66863249 | + | NR4A3 | chr9 | 102587941 | + |
5CDS-intron | ENST00000504326 | ENST00000330847 | AR | chrX | 66863249 | + | NR4A3 | chr9 | 102587941 | + |
5CDS-5UTR | ENST00000396044 | ENST00000338488 | AR | chrX | 66863249 | + | NR4A3 | chr9 | 102587941 | + |
5CDS-5UTR | ENST00000396044 | ENST00000395097 | AR | chrX | 66863249 | + | NR4A3 | chr9 | 102587941 | + |
5CDS-intron | ENST00000396044 | ENST00000330847 | AR | chrX | 66863249 | + | NR4A3 | chr9 | 102587941 | + |
5CDS-5UTR | ENST00000396043 | ENST00000338488 | AR | chrX | 66863249 | + | NR4A3 | chr9 | 102587941 | + |
5CDS-5UTR | ENST00000396043 | ENST00000395097 | AR | chrX | 66863249 | + | NR4A3 | chr9 | 102587941 | + |
5CDS-intron | ENST00000396043 | ENST00000330847 | AR | chrX | 66863249 | + | NR4A3 | chr9 | 102587941 | + |
Top |
FusionProtFeatures for AR_NR4A3 |
![]() |
Hgene | Tgene |
AR | NR4A3 |
Steroid hormone receptors are ligand-activatedtranscription factors that regulate eukaryotic gene expression andaffect cellular proliferation and differentiation in targettissues. Transcription factor activity is modulated by boundcoactivator and corepressor proteins. Transcription activation isdown-regulated by NR0B2. Activated, but not phosphorylated, byHIPK3 and ZIPK/DAPK3. {ECO:0000269|PubMed:14664718,ECO:0000269|PubMed:15563469, ECO:0000269|PubMed:17591767,ECO:0000269|PubMed:17911242, ECO:0000269|PubMed:18084323,ECO:0000269|PubMed:19345326, ECO:0000269|PubMed:20980437,ECO:0000269|PubMed:25091737}. Isoform 3 and isoform 4 lack the C-terminal ligand-binding domain and may therefore constitutively activate thetranscription of a specific set of genes independently of steroidhormones. {ECO:0000269|PubMed:19244107}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for AR_NR4A3 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for AR_NR4A3 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
AR | GNB2L1, FLNA, RAN, NR2C2, NCOA3, RNF4, NCOA4, PAK6, RANBP9, RCHY1, PIAS2, HNF4A, AKT1, IL6ST, CALM1, RAD9A, SMAD3, NCOA6, CTNNB1, CCNH, CDK7, AR, DAXX, STAT3, SP1, GSK3B, GSN, SELENBP1, HSPA1A, HSP90AA1, UXT, CAV1, JUN, PRKDC, XRCC5, XRCC6, BAG1, CREBBP, NCOA1, NCOR1, NCOR2, NCOA2, CCND1, FOXO1, FOXA1, RNF14, DCC, MAGEA11, SRC, PTEN, RB1, BRCA1, ZMIZ1, TP53, TGFB1I1, MAPK1, EGFR, GSK3A, KAT7, NR2C1, GRIP1, PELP1, SART3, HDAC3, HDAC4, TDG, PSPC1, NONO, EFCAB6, KAT5, HDAC1, CDK9, NSD1, YWHAQ, PRMT1, TSG101, COX5B, RAF1, NR0B2, POU2F1, POU2F2, DAP3, CEBPA, CEBPB, SVIL, AES, FHL2, CDC37, PIAS4, NR0B1, TMF1, SRY, CCNE1, UBE2I, SMAD4, CALR, SPDEF, PATZ1, ETV5, PA2G4, PIAS1, PIAS3, HMGB1, HMGB2, PRPF6, TRIM24, GTF2F1, GTF2F2, TBP, GTF2H1, MED1, GAPDH, CDC25B, PMEPA1, SMARCA4, SMARCC1, TRIM68, HSPB2, MDM2, WHSC1, MDN1, NLRP10, SMARCA2, ZBTB16, MED24, DENND5A, ZBTB1, MED12L, SMARCD1, SPOP, MLH3, KIFAP3, PHB, SIRT1, HDAC7, ZNF318, SMARCE1, RAD54L2, EP300, ZMIZ2, TGIF1, SREBF1, RUVBL1, KDM5B, SFPQ, GADD45GIP1, ERG, KDM4A, KDM4D, RREB1, SRCAP, TADA3, USP26, RNF6, NELFCD, STUB1, REPS2, KIF1A, RNF40, RNF20, ERCC3, ERCC2, GTF2H2, GTF2H3, CHD8, SETD7, ZBTB7A, E2F1, E2F4, PSMC3, LCOR, LATS2, ZNF451, COPS2, USP10, TAF1, TNK2, DDB2, PAX6, ARID5A, WDR77, TCF20, DCAF6, FKBP5, FKBP4, PPP5C, DNAJC7, PPID, ZBTB32, TAB2, TBL1XR1, SIN3A, SIN3B, PARK7, UBE3A, KDM3A, APPL1, SIAH2, ACTB, JMJD1C, SMAD1, VHL, CUL2, PTGES3, RBL1, USP12, SKP2, REL, WIPI1, NDE1, VCP, DAPK3, AATF, TTC5, KAT2B, IFI16, EZH2, SUZ12, EED, RNF2, BMI1, RELA, PRKG1, MID1, TCF7L2, ELF3, IDE, CDK6, ETS1, KLK3, USP7, HOTAIR, PPP1CA, AHR, WDR20, WDR48, PRPF8, PPP2CA, CACUL1, KDM1A, USP14, SMARCC2, TLE3, GSE1, ARID1A, ARID1B, BCOR, SMARCB1, KMT2D, CHD7, RCOR1, DPF1, RAI1, TFAP2A, PPP2R2A, DPF2, ARID3B, CNBP, ARID5B, NEFL, RPS21, SPATS2L, RCC2, DDX19A, KARS, SUV39H2, BRD4, BRD2, BRD3 | NR4A3 | SIX3, KDM5B, TRIM28, COPS5 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for AR_NR4A3 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Hgene | AR | P10275 | DB00421 | Spironolactone | Androgen receptor | small molecule | approved |
Hgene | AR | P10275 | DB00623 | Fluphenazine | Androgen receptor | small molecule | approved |
Hgene | AR | P10275 | DB00648 | Mitotane | Androgen receptor | small molecule | approved |
Hgene | AR | P10275 | DB00655 | Estrone | Androgen receptor | small molecule | approved |
Hgene | AR | P10275 | DB00675 | Tamoxifen | Androgen receptor | small molecule | approved |
Hgene | AR | P10275 | DB01063 | Acetophenazine | Androgen receptor | small molecule | approved |
Hgene | AR | P10275 | DB01128 | Bicalutamide | Androgen receptor | small molecule | approved |
Hgene | AR | P10275 | DB01395 | Drospirenone | Androgen receptor | small molecule | approved |
Hgene | AR | P10275 | DB01406 | Danazol | Androgen receptor | small molecule | approved |
Hgene | AR | P10275 | DB06710 | Methyltestosterone | Androgen receptor | small molecule | approved |
Hgene | AR | P10275 | DB08867 | Ulipristal | Androgen receptor | small molecule | approved |
Hgene | AR | P10275 | DB08899 | Enzalutamide | Androgen receptor | small molecule | approved |
Hgene | AR | P10275 | DB09123 | Dienogest | Androgen receptor | small molecule | approved |
Hgene | AR | P10275 | DB09371 | Norethynodrel | Androgen receptor | small molecule | approved |
Hgene | AR | P10275 | DB09389 | Norgestrel | Androgen receptor | small molecule | approved |
Hgene | AR | P10275 | DB11619 | Gestrinone | Androgen receptor | small molecule | approved |
Hgene | AR | P10275 | DB01185 | Fluoxymesterone | Androgen receptor | small molecule | approved|illicit |
Hgene | AR | P10275 | DB06412 | Oxymetholone | Androgen receptor | small molecule | approved|illicit |
Hgene | AR | P10275 | DB00255 | Diethylstilbestrol | Androgen receptor | small molecule | approved|investigational |
Hgene | AR | P10275 | DB00367 | Levonorgestrel | Androgen receptor | small molecule | approved|investigational |
Hgene | AR | P10275 | DB00499 | Flutamide | Androgen receptor | small molecule | approved|investigational |
Hgene | AR | P10275 | DB00621 | Oxandrolone | Androgen receptor | small molecule | approved|investigational |
Hgene | AR | P10275 | DB00624 | Testosterone | Androgen receptor | small molecule | approved|investigational |
Hgene | AR | P10275 | DB00665 | Nilutamide | Androgen receptor | small molecule | approved|investigational |
Hgene | AR | P10275 | DB00687 | Fludrocortisone | Androgen receptor | small molecule | approved|investigational |
Hgene | AR | P10275 | DB00957 | Norgestimate | Androgen receptor | small molecule | approved|investigational |
Hgene | AR | P10275 | DB01026 | Ketoconazole | Androgen receptor | small molecule | approved|investigational |
Hgene | AR | P10275 | DB01608 | Propericiazine | Androgen receptor | small molecule | approved|investigational |
Hgene | AR | P10275 | DB04839 | Cyproterone acetate | Androgen receptor | small molecule | approved|investigational |
Hgene | AR | P10275 | DB06713 | Norelgestromin | Androgen receptor | small molecule | approved|investigational |
Hgene | AR | P10275 | DB08604 | Triclosan | Androgen receptor | small molecule | approved|investigational |
Hgene | AR | P10275 | DB01708 | Prasterone | Androgen receptor | small molecule | approved|investigational|nutraceutical |
Hgene | AR | P10275 | DB00396 | Progesterone | Androgen receptor | small molecule | approved|vet_approved |
Tgene | NR4A3 | Q92570 | DB01254 | Dasatinib | Nuclear receptor subfamily 4 group A member 3 | small molecule | approved|investigational |
Top |
RelatedDiseases for AR_NR4A3 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | AR | C0039585 | Androgen-Insensitivity Syndrome | 73 | CTD_human;ORPHANET;UNIPROT |
Hgene | AR | C0268301 | Reifenstein Syndrome | 49 | ORPHANET;UNIPROT |
Hgene | AR | C0033578 | Prostatic Neoplasms | 20 | CTD_human |
Hgene | AR | C0011570 | Mental Depression | 5 | PSYGENET |
Hgene | AR | C0011581 | Depressive disorder | 5 | PSYGENET |
Hgene | AR | C0021364 | Male infertility | 3 | CTD_human |
Hgene | AR | C0236663 | Alcohol withdrawal syndrome | 3 | PSYGENET |
Hgene | AR | C0001973 | Alcoholic Intoxication, Chronic | 2 | PSYGENET |
Hgene | AR | C0242788 | Breast Neoplasms, Male | 2 | CTD_human |
Hgene | AR | C1458155 | Mammary Neoplasms | 2 | CTD_human |
Hgene | AR | C3658267 | Prostatic Neoplasms, Castration-Resistant | 2 | CTD_human |
Hgene | AR | C0002170 | Alopecia | 1 | CTD_human |
Hgene | AR | C0004114 | Astrocytoma | 1 | CTD_human |
Hgene | AR | C0004352 | Autistic Disorder | 1 | CTD_human |
Hgene | AR | C0017412 | Genital Diseases, Male | 1 | CTD_human |
Hgene | AR | C0020538 | Hypertensive disease | 1 | CTD_human |
Hgene | AR | C0021361 | Female infertility | 1 | CTD_human |
Hgene | AR | C0021655 | Insulin Resistance | 1 | CTD_human |
Hgene | AR | C0023418 | leukemia | 1 | CTD_human |
Hgene | AR | C0027643 | Neoplasm Recurrence, Local | 1 | CTD_human |
Hgene | AR | C0036341 | Schizophrenia | 1 | PSYGENET |
Hgene | AR | C0085207 | Gestational Diabetes | 1 | CTD_human |
Hgene | AR | C0282612 | Prostatic Intraepithelial Neoplasias | 1 | CTD_human |
Hgene | AR | C0525045 | Mood Disorders | 1 | PSYGENET |
Hgene | AR | C0556385 | Craving for alcohol | 1 | PSYGENET |
Hgene | AR | C2239176 | Liver carcinoma | 1 | CTD_human |
Tgene | NR4A3 | C0003873 | Rheumatoid Arthritis | 1 | CTD_human |
Tgene | NR4A3 | C0020443 | Hypercholesterolemia | 1 | CTD_human |
Tgene | NR4A3 | C0021655 | Insulin Resistance | 1 | CTD_human |
Tgene | NR4A3 | C3495559 | Juvenile arthritis | 1 | CTD_human |